CorEvitas has announced an expanded collaboration with healthcare analytics organization Inovalon. The partnership will further research into chronic disease, including rheumatoid arthritis and psoriasis, using real world data (RWD).
Chairman and CEO for CorEvitas Raymond Hill remarks, “As an organization, we recognize the immeasurable value of understanding the whole patient,” adding, “By furthering our collaboration with Inovalon, we can leverage the data-driven insights that provide integrated and actionable insights for the patient. This symbiotic expansion of real-world evidence will ultimately advance healthcare to its next level.” Read more here.
(Source: Cision PR Newswire, 9/21/21)